To require the Director of the Office of Management and Budget to submit to Congress an annual report on biomedical research funded by the United States and performed in China.
About This Bill
Committee
Latest Action · September 25, 2024
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
The CLAWS Act requires the Office of Management and Budget to issue guidance that directs federal agencies to submit annual reports detailing all biomedical research funded by the United States government that is conducted in China or by Chinese entities. The reports must include detailed information about each project, such as its purpose, whether it involves dangerous pathogens or dual-use research, the specific locations where work occurs, funding amounts, contractors involved, and any documented compliance issues. This requirement applies to all executive agencies and independent regulatory agencies and must go into effect within one year of the bill's enactment. The legislation does not specify new funding but rather requires agencies to compile and report information about existing research spending. The bill aims to increase transparency and oversight of federal biomedical research conducted abroad, particularly regarding projects with potential national security implications.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.